newsfilter
← Latest News
GlobeNewswire·

Trevena Announces Receipt of Nasdaq Delisting Notification

CHESTERBROOK, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system